Hyomental Distance Measured Ultrasonography Versus Weight-based Criteria for Laryngeal Mask Size Selection in Children

Hyomental Distance Measured Ultrasonography Versus Weight-based Criteria for Laryngeal Mask Size Selection in Children. A Prospective, Randomised Controlled Study

• In pediatric surgery and emergencies, LMA represents a useful airway management device for routine and difficult airway management.
• Inserting an improper LMA size may result in malposition, displacement within the hypopharynx, and failed ventilation that needs repositioning.
• Selection of the size of LMA represents a major challenge for anesthesiologists, especially in children.
• The ultrasonographic measured hyomental distance showed a correlation with the length of the pharyngeal cavity.
• Optimization of the size of the inserted LMA can be confirmed either clinically, ultrasonographic or through the fiberoptic laryngoscope.
• The ultrasonographic measured hyomental distance confirmed the optimization of LMA with results comparable to that of the clinical methods and better than those of the fiberoptic laryngoscope.

Study Overview

• Status: Recruiting
• Conditions: Laryngeal Mask Airway
• Intervention / Treatment: Device: ultrasound guided hyomental distance

Detailed Description

• The laryngeal mask airway (LMA) is classified as one of the supraglottic devices that have been extensively adopted as an adjunctive or alternative technique to tracheal intubation or mask ventilation for airway management in short-time surgery. Moreover, it is characterized by ease of placement and removal, less injury to the respiratory tract, better tolerability by patients, improved hemodynamic stability, less coughing, less sore throat, avoidance of laryngoscopy, and hands-free airway. However, it is not suitable to overcome functional airway problems and mechanical airway obstruction.
• Although the weight-based method was considered the traditional method for the selection of the optimal LMA size, a clinical practice viewed that this method is not always applicable as there is no linear correlation between the upper airway anatomy and body weight with the presence of usual individual anatomical variation.
• Fortunately, ultrasonography gave high-resolution images of the anatomic structures of the upper airway comparable to computed tomography and magnetic resonance imaging, Ultrasound measurements were applied for the hyomental distance and the hyomental distance ratio. Some studies revealed variable sensitivity and specificity.
• This prospective randomized controlled study will aim to assess the efficacy and safety of ultrasonographic measured hyomental distance in the optimization of the laryngeal mask(LMA)size selection and placement in pediatric patients Operational Design

A) Pre-anaesthetic management:

• Informed written parental consent will be taken from all participants.
• Medical history and complete clinical examination.

• Routine laboratory investigation including :

  1. CBC
  2. CRP
  3. INR, PT & PTT
• Patients will fast for at least 8 hours before surgery.
• Routine Monitoring, including heart rate (HR), oxygen saturation (SpO2) and noninvasive blood pressure (NIBP) in the pre-anaesthesia room (Base Line Data).
• A peripheral intravenous line (24-22G) will be inserted.
• A premedication of 0.01 mg/kg Atropine will be administrated IM 1 hour before surgery.

B) Induction of general anaesthesia:

• Routine monitoring, including heart rate (HR), oxygen saturation (SpO2), noninvasive blood pressure (NIBP) and continuous electrocardiography (ECG) in the operation room.
• Intravenous induction of anaesthesia will be performed using Propofol 2 mg/kg, and fentanyl 1µg/kg.
• Mechanical Ventilation: 6-8 mL/kg Tidal Volume, 10-20 bpm Respiratory Rate, end-tidal CO2 35-40 mmHg and Volume Controlled ventilation with an inspiratory-expiratory ratio of 1:2 will be initiated.
• For all patients, maintenance of anaesthesia will be performed using Sevoflurane 1-2 %. The depth of anaesthesia will be monitored according to HR.

C) Process:

1. Before starting the current study, a pilot experiment has been done, measuring the upper airway parameters of 10 children who used LMA during operation by ultrasound, investigators found that when the hyomental distance was less than 2 cm, 80% of subjects were suited for class 2 LMA and if 2-3 cm, suited for class 2.5 LMA. Additionally, size 3 LMA were fitted to the hyomental distance above 3 cm.
2. After getting ethical committee approval, and clinical trial registration, 60 pediatric participants will be scheduled for surgery using a laryngeal mask and will be divided randomly into two groups (30 in each group)

• Study Type: Interventional
• Enrollment (Anticipated): 60
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: AHMED A SHAMA, MD; Phone Number: 0580925443; Email: ahmed.shama@med.tanta.edu.eg
• Study Contact Backup: Name: SHERIF K ARAFA, MD; Phone Number: 0580925443; Email: sherifhafez1980@gmail.com

Study Locations

• Egypt
  • Cairo, Egypt, 00000
    • Recruiting
    • kafrelsheikh university, Faculty of Medicine
    • Contact: Sherif k Hafez, MD; Phone Number: 00201004397462; Email: dr_shama2000@yahoo.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Parents' acceptance
• Age: between 5-14 years
• Physical Status: American Society of Anesthesiologists (ASA) I & II)

Exclusion Criteria:

• Developmental Delay (mental and physical growth retardation).
• Hypersensitivity to any type of used drugs.
• Patient with a difficult airway ( according to thyromental height and the Mallampati test)
• Patients with a history of neck surgery
• Airway malformation.
• Upper respiratory tract infection.
• Surgeries that will take up to more than forty-five minutes.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Triple

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Group HMD (30 patients); where the size of LMA will be according to measured hyomental distance by ultrasound as follows: If Less than 2 cm: LMA size 2 will be used.; If 2-3 cm: LMA size 2.5 will be used.; If more than 3 cm: LMA size 3 will be used.	Device: ultrasound guided hyomental distance; measuring the hyomental distance by ultrasound guidance
No Intervention: Group CONTROL (30 patients); where size selection will be based on the weight guide

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
correct size selection of LMA	A five-point scale will be used to evaluate the ease of LMA insertion from 1 to 5, considering that 1 corresponds to (inserted without resistance) and 5 corresponds to (impossible to insert).	During LMA insertion (5 minutes duration)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Values of oropharyngeal leak pressure (OLP) after airway management	hearing of leakage sounds from LMA	During 30 minutes after LMA insertion
postoperative oral injury	blood adhering to the LMA surface	After removal of LMA for 5 minutes
many insertion attempts	defined as re-insertion after complete LMA removal from the oral cavity	During LMA insertion attempts for 5 minutes

Collaborators and Investigators

• Sponsor: Tanta University
• Investigators: Principal Investigator: AHMED A SHAMA, MD, Assistant professor of anesthesia in Tanta University

Study record dates

Study Major Dates

• Study Start (Anticipated): June 1, 2023
• Primary Completion (Anticipated): November 1, 2023
• Study Completion (Anticipated): January 1, 2024

Study Registration Dates

• First Submitted: April 16, 2023
• First Submitted That Met QC Criteria: April 16, 2023
• First Posted (Actual): April 27, 2023

Study Record Updates

• Last Update Posted (Actual): May 3, 2023
• Last Update Submitted That Met QC Criteria: April 28, 2023
• Last Verified: April 1, 2023

More Information

Terms related to this study

• Keywords: children; hyomental distance
• Other Study ID Numbers: MKSU 51-2-18

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No